Utilization of hepatitis C virus-infected organ donors in cardiothoracic transplantation: An ISHLT expert consensus statement
- PMID: 32362393
- DOI: 10.1016/j.healun.2020.03.004
Utilization of hepatitis C virus-infected organ donors in cardiothoracic transplantation: An ISHLT expert consensus statement
Abstract
The advent of therapies for successful treatment of hepatitis C virus has allowed the heart and lung transplant community to re-explore the use of hepatitis C virus-positive donors for organ transplantation, with a benefit for many terminally ill patients. The consensus statements provided herein represent the current state of knowledge and expertise in this area, which we expect will continue to rapidly evolve over the next few years.
Keywords: HCV; HCV+ cardiothoracic transplant; HCV+ transplant; consensus; donor; hepatitis C virus.
Copyright © 2020 International Society for Heart and Lung Transplantation. Published by Elsevier Inc. All rights reserved.
Comment in
-
COVID-19: Yet another coronavirus challenge in transplantation.J Heart Lung Transplant. 2020 May;39(5):408-409. doi: 10.1016/j.healun.2020.03.007. Epub 2020 Mar 14. J Heart Lung Transplant. 2020. PMID: 32253113 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
